Meeting
2015 ASCO Annual Meeting
HSD3B1 and resistance to androgen deprivation therapy in prostate cancer.
Authors
Jason W.D. Hearn
Cleveland Clinic, Cleveland, OH
Jason W.D. Hearn , Ghada AbuAli , Cristina Magi-Galluzzi , Chandana A. Reddy , Kai-Hsiung Chang , Eric A. Klein , Nima Sharifi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 33, 2015 (suppl; abstr 5020)
DOI
10.1200/jco.2015.33.15_suppl.5020
Abstract #
5020
Poster Bd #
12
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
HSD3B1 and resistance to androgen deprivation therapy in prostate cancer.
First Author: Jason W.D. Hearn
Poster
2015 Genitourinary Cancers Symposium
HSD3B1 and resistance to androgen deprivation therapy in prostate cancer.
First Author: Jason W.D. Hearn
Poster
2019 ASCO Annual Meeting
Outcomes of men with recurrent M0 prostate cancer who defer androgen deprivation therapy until metastasis.
First Author: Catherine Handy Marshall
Poster
2016 ASCO Annual Meeting
Development and validation of genomic signature to predict ADT treatment failure.
First Author: Jeffrey Karnes